A Biochemical analysis demonstrates that the BRCA1 intronic variant IVS10-2A→C is a mutation

被引:13
作者
Keaton, JC
Nielsen, DR
Hendrickson, BC
Pyne, MT
Scheuer, L
Ward, BE
Brothman, AR
Scholl, T
机构
[1] Myriad Genet Labs, Salt Lake City, UT 84108 USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[3] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA
[4] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA
关键词
BRCA1; splice; mutation; intron; breast cancer; mRNA;
D O I
10.1007/s10038-003-0044-0
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Sequence analysis of cDNA from an asymptomatic patient belonging to a high-risk breast cancer family carrying the genetic variant BRCA1 IVS10-2A-->C revealed that functional BRCA1 mRNA was derived from only one of the patient's chromosomes. The other chromosome produced an aberrant RNA splicing transcript that deleted exon 11. Analysis of the patient's genomic DNA demonstrated that the chromosome producing the non-functional mRNA carried the genotype BRCA1 IVS10-2A-->C. This transversion disrupts a highly conserved base in the consensus splice acceptor motif. These results support the conclusion that BRCA1 IVS10-2A-->C is a mutation that confers predisposition to breast and ovarian cancer.
引用
收藏
页码:399 / 403
页数:5
相关论文
共 12 条
[1]   EXON RECOGNITION IN VERTEBRATE SPLICING [J].
BERGET, SM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (06) :2411-2414
[2]   CONFIRMATION OF BRCA1 LAY ANALYSIS OF GERMLINE MUTATIONS LINKED TO BREAST AND OVARIAN-CANCER IN 10 FAMILIES [J].
FRIEDMAN, LS ;
OSTERMEYER, EA ;
SZABO, CI ;
DOWD, P ;
LYNCH, ED ;
ROWELL, SE ;
KING, MC .
NATURE GENETICS, 1994, 8 (04) :399-404
[3]  
Lu ML, 1996, CANCER RES, V56, P4578
[4]   A STRONG CANDIDATE FOR THE BREAST AND OVARIAN-CANCER SUSCEPTIBILITY GENE BRCA1 [J].
MIKI, Y ;
SWENSEN, J ;
SHATTUCKEIDENS, D ;
FUTREAL, PA ;
HARSHMAN, K ;
TAVTIGIAN, S ;
LIU, QY ;
COCHRAN, C ;
BENNETT, LM ;
DING, W ;
BELL, R ;
ROSENTHAL, J ;
HUSSEY, C ;
TRAN, T ;
MCCLURE, M ;
FRYE, C ;
HATTIER, T ;
PHELPS, R ;
HAUGENSTRANO, A ;
KATCHER, H ;
YAKUMO, K ;
GHOLAMI, Z ;
SHAFFER, D ;
STONE, S ;
BAYER, S ;
WRAY, C ;
BOGDEN, R ;
DAYANANTH, P ;
WARD, J ;
TONIN, P ;
NAROD, S ;
BRISTOW, PK ;
NORRIS, FH ;
HELVERING, L ;
MORRISON, P ;
ROSTECK, P ;
LAI, M ;
BARRETT, JC ;
LEWIS, C ;
NEUHAUSEN, S ;
CANNONALBRIGHT, L ;
GOLDGAR, D ;
WISEMAN, R ;
KAMB, A ;
SKOLNICK, MH .
SCIENCE, 1994, 266 (5182) :66-71
[5]   The BRCA2 genetic variant IVS7+2T→G is a mutation [J].
Pyne, MT ;
Brothman, AR ;
Ward, B ;
Pruss, D ;
Hendrickson, BC ;
Scholl, T .
JOURNAL OF HUMAN GENETICS, 2000, 45 (06) :351-357
[6]   A characterization of genetic variants in BRCA1 intron 8 identifies a mutation and a polymorphism [J].
Pyne, MT ;
Pruss, D ;
Ward, BE ;
Scholl, T .
MUTATION RESEARCH-GENOMICS, 1999, 406 (2-4) :101-107
[7]  
Scholl T, 1999, AM J MED GENET, V85, P113, DOI 10.1002/(SICI)1096-8628(19990716)85:2<113::AID-AJMG3>3.0.CO
[8]  
2-V
[9]   BRCA 1 sequence analysis in women at high risk for susceptibility mutations - Risk factor analysis and implications for genetic testing [J].
ShattuckEidens, D ;
Oliphant, A ;
McClure, M ;
McBride, C ;
Gupte, J ;
Rubano, T ;
Pruss, D ;
Tavtigian, SV ;
Teng, DHF ;
Adey, N ;
Staebell, M ;
Gumpper, K ;
Lundstrom, R ;
Hulick, M ;
Kelly, M ;
Holmen, J ;
Lingenfelter, B ;
Manley, S ;
Fujimura, F ;
Luce, M ;
Ward, B ;
CannonAlbright, L ;
Steele, L ;
Offit, K ;
Gilewski, T ;
Norton, L ;
Brown, K ;
Schulz, C ;
Hampel, H ;
Schluger, A ;
Giulotto, E ;
Zoli, W ;
Ravaioli, A ;
Nevanlinna, H ;
Pyrhonen, S ;
Rowley, P ;
Loader, S ;
Osborne, MP ;
Daly, M ;
Tepler, I ;
Weinstein, PL ;
Scalia, JL ;
Michaelson, R ;
Scott, RJ ;
Radice, P ;
Pierotti, MA ;
Garber, JE ;
Isaacs, C ;
Peshkin, B ;
Lippman, ME .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (15) :1242-1250
[10]   Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells [J].
Xu, XL ;
Weaver, Z ;
Linke, SP ;
Li, CL ;
Gotay, J ;
Wang, XW ;
Harris, CC ;
Ried, T ;
Deng, CX .
MOLECULAR CELL, 1999, 3 (03) :389-395